Cargando…

286. Hepatitis B Vaccine Compliance: Comparing 2-Dose and 3-Dose Vaccines

BACKGROUND: Less than 1 in 3 US adults who initiated the 3-dose (0, 1, 6 months) hepatitis B vaccine series have completed it. HepB-CpG (Heplisav-B; Dynavax) is a new licensed adjuvanted vaccine that requires only 2 doses (0, 1 month). As part of a cluster study performed at Kaiser Permanente Southe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruxvoort, Katia, Slezak, Jeff, Huang, Runxin, Sy, Lina S, Towner, William, Ackerson, Bradley, Reynolds, Kristi, Qian, Lei, Carlson, Cheryl M, Solano, Zendi, Hyer, Randall N, Janssen, Robert, Jacobsen, Steven J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810827/ http://dx.doi.org/10.1093/ofid/ofz360.361

Ejemplares similares

Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults
por: Bruxvoort, Katia, et al.
Publicado: (2020)

115. Post-licensure Safety Study of New-onset Immune-mediated Diseases, Herpes Zoster, and Anaphylaxis in Adult Recipients of HepB-CPG Vaccine Versus HepB-alum Vaccine
por: Ackerson, Bradley, et al.
Publicado: (2022)

Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example
por: Bruxvoort, Katia, et al.
Publicado: (2021)

19. Completion of Two-Dose Recombinant Zoster Vaccine Series in Adults 50 Years and Older
por: Tseng, Hung-Fu, et al.
Publicado: (2020)

Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
por: Bruxvoort, Katia J, et al.
Publicado: (2021)

Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults
por: Ackerson, Bradley, et al.
Publicado: (2019)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines
por: Luna-Casas, Gerardo, et al.
Publicado: (2018)

Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study
por: Ku, Jennifer H., et al.
Publicado: (2023)

Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
por: Slezak, Jeff, et al.
Publicado: (2021)

Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study
por: Xu, Stanley, et al.
Publicado: (2023)

Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model
por: Patterson, Brandon J, et al.
Publicado: (2020)

286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia
por: Rottenstreich, Amihai, et al.
Publicado: (2023)

2287. Recently Approved HEPLISAV-B(R) [Hepatitis B Vaccine (Recombinant), Adjuvanted] Shows a Higher Proportion of Subjects Achieving Seroprotection With a More Consistent Immune Response Compared With Engerix-B(R) [Hepatitis B Vaccine (Recombinant)] in Three Comparative Trials
por: Hyer, Randall N, et al.
Publicado: (2018)

784. Real-world effectiveness of the mRNA-12733-dose primary series against COVID-19 in an immunocompromised population Interim results from a prospective observational cohort study
por: Ku, Jennifer H, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children
por: Krishnarajah, Girishanthy, et al.
Publicado: (2018)

Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study
por: Bruxvoort, Katia J., et al.
Publicado: (2021)

Thromboembolism after COVID-19 Vaccination: A Systematic Review of Such Events in 286 Patients
por: Mani, Avinash, et al.
Publicado: (2022)

Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study
por: Ku, Jennifer H., et al.
Publicado: (2023)

Differences in Estimates of Post-Herpetic Neuralgia Between Medical Chart Review and Self-Report
por: Tanenbaum, Hilary C, et al.
Publicado: (2020)

Vaccine dosing controversy
por: Wilson, Clare
Publicado: (2021)

Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
por: Hyer, Randall N.
Publicado: (2022)

Compliance with birth dose of Hepatitis B vaccine in high endemic and hard to reach areas in the Colombian amazon: results from a vaccination survey
por: Choconta-Piraquive, Luz Angela, et al.
Publicado: (2016)

Health Tract, No. 286: Bread Making
Publicado: (1867)

P286 Histoplasmosis in Sri Lanka
por: Sigera, Liyanage Shamithra Madhumali, et al.
Publicado: (2022)

1084 Persistence of Meningococcal Antibodies and Response to a Booster Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents
por: Saez-Llorens, Xavier, et al.
Publicado: (2014)

NACI greenlights second doses, dose splitting of monkeypox vaccine
por: Vogel, Lauren
Publicado: (2022)

530 Disease Modulation in Older Adults Vaccinated with High-Dose Versus Standard-Dose Influenza Vaccine
por: Talbot, H. Keipp, et al.
Publicado: (2014)

Split dosing of coronavirus disease 2019 vaccines provides noninferior antibody responsiveness to conventional vaccine dosing
por: Musa, Amal, et al.
Publicado: (2022)

Relative Effectiveness of COVID-19 Vaccination in Healthcare Workers: 3-Dose Versus 2-Dose Vaccination
por: Kim, Sung Ran, et al.
Publicado: (2022)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest
por: Verdenius, Inge, et al.
Publicado: (2013)

Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study
por: Tartof, Sara Y., et al.
Publicado: (2022)

Vaccine vial stopper performance for fractional dose delivery of vaccines
por: Jarrahian, Courtney, et al.
Publicado: (2017)

Invalid measles vaccine dose administration and vaccine effectiveness in Ethiopia
por: Desta, Teklay, et al.
Publicado: (2021)

Parent intentions to vaccinate children with autism spectrum disorder against COVID-19
por: Choi, Kristen, et al.
Publicado: (2022)

Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness
por: Langer-Gould, Annette, et al.
Publicado: (2023)

Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines
por: Wolff, Jonathan, et al.
Publicado: (2021)

SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING
por: Musa, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9bf4ll9m26jgvs6b8t8ranh83k